home / openregs / legislation

legislation: 98-hr-6034

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
98-hr-6034 98 hr 6034 Agricultural Patent Reform Act of 1984 Commerce 1984-07-26 1984-10-01 Placed on Union Calendar No: 633. House Rep. Glickman, Dan [D-KS-4] KS D G000240 26 (Reported to House from the Committee on the Judiciary with amendment, H. Rept. 98-1122) Agricultural Patent Reform Act of 1984 - Amends the patent laws to extend the terms of patents which encompass specified products or methods for using a product, including methods of manufacturing which primarily use recombinant DNA technology, any of which are subject to certain nonpatent regulatory review periods. Sets forth the terms and conditions of such extension, including a five year limitation on the extension and a 25 year maximum patent term from the earliest filing. Directs the Commissioner of Patents to notify the appropriate Federal agency upon receipt from a product sponsor of a notice of extension. Requires the notified agency to determine the applicable regulatory review period and whether, within that period, the sponsor acted with due diligence. Provides for notice and informal hearings for persons interested in such determinations. Permits the appropriate Secretary or Administrator to consider the failure of a product sponsor to submit data which such sponsor should have known was necessary to support an extension notice. Permits the appropriate Secretary or Administrator to establish fees to cover review costs. Directs the Commissioner, upon a final determination of the applicable regulatory review period, to issue to the owner of record of a patent a certificate of extension stating the fact and length of the extension and identifying the product and the use and the claim to which such extension is applicable. Makes such certificate a part of the original patent. Restricts the disclosure of any data submitted during the regulatory review period which is designated as a trade secret or confidential. Limits the application of such patent term extension to patents for: (1) any new animal drug or antibiotic subject to regulation under the Federal Food, Drug, and Cosmetic Act; (2) any veterinary biological product subject to regulation under the Virus-Serum- Toxin Act; (3) any pesticide subject to regulation under the Federal Insecticide, Fungicide, and Rodenticide Act; and (4) any chemical substance or mixture subject to regulation under the Toxic Substances Control Act. 2021-06-29T21:23:00Z  

Links from other tables

  • 9 rows from bill_id in legislation_actions
  • 15 rows from bill_id in legislation_subjects
  • 26 rows from bill_id in legislation_cosponsors
  • 0 rows from bill_id in cbo_cost_estimates
Powered by Datasette · Queries took 0.315ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API